相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。
Article
Obstetrics & Gynecology
M. C. Magnus et al.
Summary: The study found that pregnant women were not more likely to be infected with SARS-CoV-2, but pregnant women, especially those born outside of Scandinavia, were more likely to be hospitalized with COVID-19.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Sarah J. Stock et al.
Summary: Population-level data on COVID-19 vaccine uptake in pregnancy and SARS-CoV-2 infection outcomes are lacking. However, this study reveals low levels of vaccination uptake by pregnant women compared to women in the general population and that not being vaccinated is associated with increased risk of severe complications of COVID-19 in pregnancy, including perinatal mortality.
Review
Health Care Sciences & Services
Malik Sallam et al.
Summary: The delay or refusal of vaccination poses a major challenge to controlling the COVID-19 epidemic. Global acceptance rates of the COVID-19 vaccine vary greatly among different countries and regions, with higher rates in Asia and the Pacific and lower rates in the Middle East and North Africa.
JOURNAL OF MULTIDISCIPLINARY HEALTHCARE
(2022)
Article
Obstetrics & Gynecology
Helena Blakeway et al.
Summary: This study investigates the uptake and safety of COVID-19 vaccination among pregnant women. The results show that the proportion of vaccinated pregnant women is low, and those who received the vaccine experienced similar pregnancy outcomes compared to unvaccinated pregnant women. There is lower uptake among younger women, non-White ethnicity, and lower socioeconomic background. This study contributes to the evidence on the safety of COVID-19 vaccination in pregnancy and emphasizes the importance of improving awareness among pregnant women and healthcare professionals on vaccine safety.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
(2022)
Article
Medicine, General & Internal
Maria C. Magnus et al.
Summary: This population-based study conducted in Sweden and Norway showed that vaccination against SARS-CoV-2 during pregnancy, compared with no SARS-CoV-2 vaccination during pregnancy, was not significantly associated with an increased risk of adverse pregnancy outcomes. The majority of vaccinations were administered with mRNA vaccines during the second and third trimesters of pregnancy, which should be considered when interpreting the findings.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2022)
Article
Immunology
Rickard Ljung et al.
Summary: Vaccine coverage among healthcare workers in Sweden varies by occupation group and region of birth. Physicians have the highest coverage, followed by registered nurses, licensed practical nurses, and nurse aides. The difference in vaccine coverage by region of birth among healthcare workers may be influenced by socioeconomic inequalities and sociocultural beliefs.
Review
Multidisciplinary Sciences
Smriti Prasad et al.
Summary: This study evaluated evidence from 23 studies and found that COVID-19 mRNA vaccines are safe and effective during pregnancy. Vaccination reduces the risk of infection and stillbirth. There is no evidence of adverse outcomes associated with vaccination.
NATURE COMMUNICATIONS
(2022)
Article
Medicine, General & Internal
Ellen Oen Carlsen et al.
Summary: A Norwegian cohort study found that infants born to mothers who were vaccinated against COVID-19 during pregnancy had a lower risk of testing positive for COVID-19 during the first 4 months of life. This suggests that maternal vaccination may provide passive protection to young infants.
JAMA INTERNAL MEDICINE
(2022)
Article
Public, Environmental & Occupational Health
Malia Skjefte et al.
Summary: The study found that COVID-19 vaccine acceptance among pregnant women and mothers of young children varied globally, with higher acceptance rates in India, the Philippines, and Latin American countries, and lower rates in Russia, the United States, and Australia. The main predictors of vaccine acceptance included confidence in vaccine safety and effectiveness, concern about COVID-19, trust in public health agencies, adherence to mask guidelines, and attitudes towards routine vaccines.
EUROPEAN JOURNAL OF EPIDEMIOLOGY
(2021)
Article
Medicine, General & Internal
Noa Dagan et al.
Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Immunology
Tamar Wainstock et al.
Summary: The study found that prenatal administration of the Pfizer-BioNTech COVID-19 vaccine has no adverse effects on pregnancy course and outcomes. Women who received the vaccine during pregnancy were typically older, more likely to conceive following fertility treatments, and received more prenatal care, but there were no significant differences in pregnancy, delivery, or newborn complications compared to unvaccinated women.
Review
Immunology
Malik Sallam
Summary: COVID-19 vaccine acceptance rates are generally high worldwide, but low rates are reported in the Middle East, Russia, Africa, and certain European countries. This could pose a significant challenge in global efforts to control the pandemic. More studies are recommended to address COVID-19 vaccine hesitancy in different regions.
Article
Pediatrics
Jose Villar et al.
Summary: This study evaluated the risks associated with COVID-19 in pregnancy on maternal and neonatal outcomes compared with pregnant individuals without COVID-19, finding that pregnant individuals with COVID-19 were at higher risk for various complications such as preeclampsia, severe infections, and preterm birth. The findings emphasize the importance for pregnant individuals and clinicians to strictly implement recommended COVID-19 preventive measures.
Article
Medicine, General & Internal
Inbal Goldshtein et al.
Summary: The retrospective cohort study found that BNT162b2 mRNA vaccination in pregnant women was associated with a significantly reduced risk of SARS-CoV-2 infection compared to no vaccination. However, interpretation of the study findings is limited by the observational design.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2021)
Review
Medicine, General & Internal
Fidelia Cascini et al.
Summary: Acceptance rates of COVID-19 vaccines vary significantly between countries and time points, with Arabian countries showing higher hesitancy rates. Factors contributing to hesitancy include negative perceptions of vaccine efficacy, safety, convenience, and price. Certain socio-demographic groups identified with lower vaccine acceptance rates include women, younger participants, and individuals with lower education level, income, insurance coverage, living in rural areas, and identifying as racial/ethnic minorities.
Review
Public, Environmental & Occupational Health
Antony Raharja et al.
Summary: This study found that compared to White ethnicity, Black and Asian populations had similar overall mortality rates, while Hispanic ethnicity had lower overall mortality rates. After adjusting for age, sex, and comorbidities, the elevated risks for Black and Asian populations became non-significant. There was a trend towards greater disparities in COVID-19 outcomes for ethnic minorities in the UK.
JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES
(2021)
Review
Medicine, General & Internal
John Allotey et al.
BMJ-BRITISH MEDICAL JOURNAL
(2020)
